REFERENCES
- Fung TY, Lau TK, Tam WH, Li CK. In utero exchange transfusion in homozygous α-thalassaemia: A case report. Prenat Diagn. 1998; 18(8)838–841
- Sohan K, Billington M, Pamphilon D, Goulden N, Kyle P. Normal growth and development following in utero diagnosis and treatment of homozygous α-thalassaemia. BJOG. 2002; 109(11)1308–1310
- Chui DHK, Waye JS. Hydrops fetalis caused by α-thalassemia: An emerging health care problem. Blood. 1998; 91(7)2213–2222
- Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, et al. The prevalence and spectrum of α and β thalassemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004; 57(5)517–522
- Chui DHK. α-Thalassemia: Hb H disease and Hb Bart's hydrops fetalis. Ann N Y Acad Sci. 2005; 1054: 25–32
- Liao C, Li Q, Wei J, Feng Q, Li J, Huang Y, Li D. Prenatal control of Hb Bart's disease in southern China. Hemoglobin. 2007; 31(4)471–475
- Liao C, Mo QH, Li J, Li LY, Huang YN, Hua L, et al. Carrier screening for α- and β-thalassemia in pregnancy: the results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital. Prenat Diagn. 2005; 25(2)163–171